Sign in

CIK 0001590750

  • Large accelerated filer

Viridian Therapeutics, Inc.DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471187261
Phone
+1 617-272-4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-03 Harmon Seth Chief Financial Officer Shares withheld for taxes −2,031 $30.19 $61K 7,850
2026-03-03 Harmon Seth Chief Financial Officer Exercise or conversion +6,267 9,881
2026-03-03 Harmon Seth Chief Financial Officer Shares withheld for taxes −2,091 $29.32 $61K 7,790
2026-03-03 Harmon Seth Chief Financial Officer Exercise or conversion · Restricted Stock Units −6,267 18,801
2026-03-02 Harmon Seth Chief Financial Officer Grant or award · Stock Option (Right to Buy) +102,850 102,850
2026-03-02 Harmon Seth Chief Financial Officer Grant or award · Restricted Stock Units +20,550 20,550
2025-03-03 Harmon Seth Chief Financial Officer Grant or award · Stock Option (Right to Buy) +150,407 150,407
2025-03-03 Harmon Seth Chief Financial Officer Grant or award · Restricted Stock Units +25,068 25,068
2023-11-10 Harmon Seth Grant or award · Stock Option (Right to Buy) +270,000 270,000

Page 1 of 1 · 9 trades